We're pleased to share our 2025 #annualreport: Reimagining The Possible. It was a year defined by resilience, focus & forward momentum. Read about our collab w/ @IonQ_Inc, progress w/ @CCRM_au & Nordic, successes at our #GMP #CDMO & @CATTI_Training & more ccrm.ca/regenerative-medicin…

📢 The ISSCR is now accepting nominations for the 2027 ISSCR Board of Directors and the Society's annual awards. Nominations are due 16 October. Learn more 👉isscr.org/isscr-news/get-inv…

When knowledge is shared across sectors, the rare disease community can find answers faster and close gaps in care and access. Join the 2026 NORD Breakthrough Summit, Oct. 25–27 in Washington, DC, to exchange ideas and build new connections. ASGCT staff will be there to connect you with patient education resources (including our new coloring book!), and discuss the latest policies affecting rare disease research and individuals. Learn more ➡️ nordsummit.org #NORDSummit #RareDisease

Last chance—GEN's State of Biotech is tomorrow. Maraganore. Orkin. Google Cloud's Shweta Maniar. The Biotech Hangout hosts. And John Sterling's exit interview after four decades as GEN's Editor in Chief. Free registration: hubs.li/Q04x-T-z0 #biotech #stateofbiotech

Musings from @MichaelMay5 via The Medicine Maker's Power List. Shoutouts to @IonQ_Inc, @BlueRockTx and #DeepTechBioLab themedicinemaker.com/issues/…

Is this you?

Timely topic

Just as @CBCNews is reporting about doctor #deepfake videos, @msstaceyerin has a timely blog post exploring the topic of who we can trust online with our health: signalsblog.ca/right-turn-he… Studies from @CaulfieldTim, Megan Munsie, @pewresearch @CMA_Docs

A fifth cell and gene therapy product has been approved in the US this year. Today, the FDA announced approval of an AAV gene therapy developed by ARM member Ultragenyx to treat pediatric patients with Sanfilippo syndrome Type A. 1/2 fda.gov/news-events/press-an…

Banner week for #DeepTechBioLab: 1st a workshop at @IEEEQuantumWeek & then an event in the @biolabs @UofT space, with presentations & a panel. Want to learn more how we are bringing together #DeepTech companies with #lifesciences? ccrm.ca/deeptech-bio-lab/ @IonQ_Inc @KausarSamli

How do we make CGTs more accessible to patients globally? In the new episode of our podcast, @bambi_grilley & #StaciArnold explore manufacturing & delivery challenges, regulation, P3s & more. Listen where you stream podcasts or at ccrm.ca/podcast. @KristaLambComms

📣 Signals is looking for talented bloggers to write about the #regenerativemedicine and #CGT fields. signalsblog.ca/ If you’re passionate about cutting-edge science and can turn complex ideas into compelling content, we want to hear from you. DM us to learn more #scicomm

Submit an abstract to the Inaugural Canadian Gene and Cell Therapy Conference by October 1! Early-career investigators and trainees are invited to submit abstracts highlighting advances across the cell and gene therapy landscape from basic discovery through to clinical implementation. Accepted abstracts will be presented as posters, with selected submissions invited for short oral presentations. For more information or to submit an abstract, visit cancgt.ca.

FDA clears trial of dual-targeted CAR T-cell therapy for cancer news-medical.net/news/202609…

Thank you to @CIHR_IRSC for supporting this research! Learn more about how the LUMI-Lab and @UHN researchers (@BowenLi_Lab, @BoWang87, @HAOTIANCUI1, @Yuexulab) are using #AI-enabled robotics to accelerate molecular discovery. ➡️: uhnresearch.ca/news/4-16-202…

The ISSCR recently submitted comments to the #FDA draft guidance for Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing. Read the comments. isscr.org/isscr-news/the-iss…

The FDA’s proposal to offer 50% off application fees for drugs with early-stage trials conducted in the U.S. is unlikely to achieve the intended result. What biotechs really want is speed. hubs.li/Q04x77Sp0

The 2026 #CellsISee People’s Choice Award voting is now open! "Like" your favourite and the lucky winner will receive $500 at #TMM2026. The #sciart #contest is co-hosted with @StemCellNetwork Vote here: facebook.com/media/set/?vani… Pls RT

UCLA scientists have developed a scalable method for turning blood stem cells from donated cord blood into uniform batches of cancer-fighting T cells engineered to recognize a protein found in many solid tumors. 🔗 ow.ly/MlGv50ZL408 #ResearchPowersProgress

Happening today!! Join us for today's #TissueTalk with Prof. Karen Christman @ChristmanLab from @ucsdbe happening at 3pm EST where she will discuss her group's work on "Injectable biomaterials for women's health." See you there: bit.ly/tissuetalks

Betting markets on patient lives is bad enough. The conflict of interest and policing insider information is near impossible when hundreds or thousands of people may possess fragments of nonpublic information about a multicenter clinical trial, and some of them participate directly in data collection and analysis. I support this Change.org petition to Ban prediction markets from betting on the outcomes of life-saving clinical trials change.org/p/ban-prediction-…